A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Tazarotene/ulobetasol (Primary) ; Tazarotene
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Valeant Pharmaceuticals International
- 25 Apr 2017 Status changed from recruiting to completed.
- 18 Jul 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jul 2016.
- 01 Jun 2016 New trial record